Colorectal cancer, sometimes referred to as bowel cancer, is Europe’s second deadliest cancer. Every year, 400,000 citizens in the European…
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
Resolution of the European Parliament over the Artificial Intelligence: fundamental to assist diagnosis, robot-assisted surgery, smart prostheses, personalised treatments and other more
The European Parliament published on 20 January 2021 a resolution on “Artificial intelligence: questions of interpretation and application of international…
Presented the Europe’s Beating Cancer Plan of the European Commission: a new EU approach to prevention, treatment and care
The European Commission presented last February the 3rd the Europe’s Beating Cancer Plan, one of the main priority in the…
Drug discovery with explainable artificial intelligence
In the Nature Research Journal, a review about Nature Machine Intelligence by J. Jiménez-Luna, F. Grisoni and G. Schneider, dealing…
Revert presented by the Catholic University of Murcia (UCAM) at the webinar: “Computational methods for drug discovery”
Revert, the European project financed by the European Commission under the Horizon 2020 call, participates through its partner Catholic University…
“The project was both educational and fun”
The department of Biomedical science, Malmö University, Malmö – Sweden – hosted the high school student Dalya Abou Alhaija for…
“Designing an Optimal Colorectal Cancer Screening Process in Europe”: The Thematic Network 2020 on Colorectal Cancer (CRC) Screening led by the Digestive Cancer Europe
Digestive Cancer Europe is the European umbrella organisation of a large group of national Members representing patients with digestive cancer.…
“When will the mist clear? On the Interpretability of Machine Learning for Medical Applications: a survey”
Artificial Intelligence is providing astonishing results, with medicine being one of its favourite playgrounds. In the short-term future, computers may…
How REVERT can face the challenges of the European Mission on Cancer
The “mission” of the European Commission for the 2021 – 2017 Programming Period is to engage citizens in a continuous…
The European Code of Cancer Practice: how to implement good clinical practices
The European Cancer Organization recently launched the Code for Cancer Practice. The European Code of Cancer Practice (The Code) is…
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.